Cargando…

POLYPHARMACY IN ASSISTED LIVING

The purpose of this study was to describe polypharmacy in assisted living settings, evaluate the factors that influence polypharmacy and the impact of polypharmacy on clinical outcomes. Baseline data from the study entitled, Dissemination and Implementation of Function Focused Care for Assisted Livi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Galik, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770386/ http://dx.doi.org/10.1093/geroni/igac059.992

Ejemplares similares

Examining Satisfaction With Assisted Living Among Residents With and Without Dementia
por: Holmes, Sarah, et al.
Publicado: (2020)

The Influence of Staff-Resident Interactions on Resistiveness to Care Behavior in Assisted Living
por: McPherson, Rachel, et al.
Publicado: (2021)

THE INCIDENCE AND IMPACT OF POLYPHARMACY IN AL RESIDENTS
por: Galik, Elizabeth
Publicado: (2019)

The Impact of COVID-19 and Associated Restrictions on Physical Activity Among Assisted Living Residents
por: Galik, Elizabeth, et al.
Publicado: (2021)

POLYPHARMACY IN ASSISTED LIVING: WHERE ARE WE NOW AND EFFECTIVE APPROACHES TO IMPROVE MEDICATION MANAGEMENT
por: Resnick, Barbara
Publicado: (2022)

Factors Associated With the Quality of Staff-Resident Interactions in Assisted Living
por: Paudel, Anju, et al.
Publicado: (2021)

Pilot Testing of the Promoting Positive Care Interactions (PPCI) in Assisted Living Study During a Pandemic
por: Paudel, Anju, et al.
Publicado: (2021)

Teaching Nurse Practitioner Students About Polypharmacy Through a Lived Experience
por: Kim, Jennifer, et al.
Publicado: (2020)

1494. Impact of Polypharmacy on Gait Speed and Falls in Older People Living with HIV.
por: Kosana, Priya, et al.
Publicado: (2023)

581. Do Comorbidities and Polypharmacy Lead to Virologic Failure in All Populations Living with HIV?
por: Jimenez, Humberto, et al.
Publicado: (2018)

DEVELOPING AND TESTING AN ASSISTED LIVING ENVIRONMENT MODEL
por: Holmes, Sarah D, et al.
Publicado: (2019)

Polypharmacy and relapse of schizophrenia: are they related?
por: Softic, R., et al.
Publicado: (2022)

The impact of COVID-19 in an assisted living community
por: Resnick, Barbara, et al.
Publicado: (2021)

Nurse Practitioners’ Experiences of Polypharmacy in Community-Dwelling Older Adults
por: Pariseault, Christine, et al.
Publicado: (2020)

Polypharmacy and Potentially Inappropriate Medications in Patients With Dementia
por: Nonaka, Ryo, et al.
Publicado: (2020)

Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020)

OVERCOMING RECRUITMENT APPROACHES TO IDENTIFY PARTICIPANTS WITH DEMENTIA
por: Galik, Elizabeth
Publicado: (2022)

Effectiveness of the EIT-4-BPSD Intervention on Resident and Setting Outcomes
por: Galik, Elizabeth
Publicado: (2021)

The Effectiveness of FFC-AL-EIT on Psychosocial Outcomes and Care Interactions
por: Galik, Elizabeth
Publicado: (2021)

Adverse Outcomes, Polysubstance Use, and Polypharmacy in Older Veterans
por: Byers, Amy
Publicado: (2020)

The Lived Experience of Assisted Living Administrators During the COVID-19 Pandemic
por: Hill, Elizabeth, et al.
Publicado: (2021)

Electronic Assisted Living Technology in CCRC, Assisted Living, and In-Home Care
por: Hall, John, et al.
Publicado: (2020)

Implementation of Function and Behavior Focused Care
por: Resnick, Barbara, et al.
Publicado: (2020)

Lessons Learned From the Function and Behavior Focused Care Trial: From Efficacy to Implementation
por: Galik, Elizabeth, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients
por: Shiri, M., et al.
Publicado: (2022)

Rising CNS Polypharmacy Among Older Adults in the United States
por: Maust, Donovan
Publicado: (2020)

Identifying Domains of Assisted Living Quality for Minnesota’s Assisted Living Report Card
por: Shippee, Tetyana, et al.
Publicado: (2020)

Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012)

71. Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States
por: Paudel, Misti, et al.
Publicado: (2021)

Irrational polypharmacy and potentially inappropriate medications in patients with dementia: Treatment strategies
por: Štuhec, M.
Publicado: (2023)

Psychoactive Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

FACTORS ASSOCIATED WITH EATING PERFORMANCE IN NURSING HOME RESIDENTS WITH DEMENTIA AND MULTIPLE COMORBIDITIES
por: Liu, Wen, et al.
Publicado: (2022)

Facilitators and Barriers to the Implementation of Function and Behavior Focused Care
por: Vigne, Erin, et al.
Publicado: (2020)

Measurement Opportunities and Challenges With Long-Term Care Residents With Dementia
por: Holmes, Sarah, et al.
Publicado: (2020)

The Quality of Interactions Between Staff and Residents With Cognitive Impairment in Nursing Homes
por: Paudel, Anju, et al.
Publicado: (2020)

Factor Analysis of the Short Form Cohen Mansfield Agitation Inventory and Measurement Invariance by Gender
por: Paudel, Anju, et al.
Publicado: (2020)

Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
por: Konstantinidis, Anastasios
Publicado: (2010)

POLYPHARMACY, FRAILTY, AND DISABILITY-FREE SURVIVAL IN COMMUNITY-DWELLING HEALTHY OLDER INDIVIDUALS
por: Ekram, A R M Saifuddin, et al.
Publicado: (2022)

High-Risk Medication Use and Polypharmacy in Older Veterans Who Attempt Suicide
por: Morin, Ruth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6k06iblcrmou23qm9nt39d287b